Table 5 Knowledge, education and uptake of serological screening for various congenital infections according to risk group
Population A (n = 799) | Population B (n = 434) | |||||
|---|---|---|---|---|---|---|
Average-risk group (n = 542) | High-risk group (n = 257) | p-value | Average-risk group (n = 188) | High-risk group (n = 246) | p-value | |
Knowledge toxoplasmosis | 529 (97.6%) | 253 (98.4%) | 0.248 | 174 (92.6%) | 230 (93.5%) | 0.49 |
Education toxoplasmosis | 502 (92.6%) | 245 (95.3%) | 0.043 | 164 (87.2%) | 217 (88.2%) | 0.986 |
Toxoplasmosis serological screening | 462 (85.2%) | 212 (82.5%) | 0.338 | 136 (72.3%) | 183 (74.4%) | 0.986 |
Knowledge listeriosis | 334 (61.6%) | 171 (66.5%) | 0.136 | 99 (52.7%) | 152 (61.8%) | 0.057 |
Education listeriosis | 279 (51.5%) | 147 (57.2%) | 0.244 | 90 (47.9%) | 127 (51.6%) | 0.356 |
Knowledge CMV | 228 (42.1%) | 162 (63.0%) | < 0.001 | 68 (36.2%) | 141 (57.3%) | < 0.001 |
Education CMV | 174 (32.1%) | 133 (51.8%) | < 0.001 | 58 (30.9%) | 106 (43.1%) | 0.008 |
CMV serological screening | 148 (27.3%) | 112 (43.6%) | < 0.001 | 47 (25.0%) | 86 (35.0%) | 0.034 |
Knowledge chlamydiasis | 516 (95.2%) | 252 (98.1%) | 0.014 | 169 (89.9%) | 224 (91.1%) | 0.486 |
Education chlamydiasis | 346 (63.8%) | 186 (72.4%) | 0.043 | 122 (64.9%) | 154 (62.6%) | 0.616 |